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Location  Sense shRNA sequence 5’ ‐> 3’ 8  Inter‐genic region  21/22  8  CCGTCTCCAGACATTTAAAGAT 9  Inter‐genic region  21/22  1  CTGAAGATGTACTGGAACTAAA 








































































































































































0  10  20  30  40  50  60 
W
ei
gh
t (
gr
am
s)
 
Days after Birth 
Sox2‐Cre/Smurf2 Sox2‐Cre 
Smurf2  tubulin 
  32 
  The gene expression of Smurf2, p21, and p16 was determined using an assay more sensitive than a Western blot. RNA was extracted from spleen and analyzed using real‐time PCR. As seen in Figure 15, Smurf2 and p21 RNA is overexpressed in Sox2‐Cre/Smurf2 (blue) mice when compared to Sox‐Cre (red) mice. The data also shows that p16 is not overexpressed in Sox2‐Cre/Smurf2 mice.  
 
Figure 15: Smurf2 and p21 RNA is Overexpressed in Sox2‐Cre/Smurf2 mice. RNA was extracted from spleen in Sox2‐Cre (blue) and Sox2‐Cre/Smurf2 (red) mice. Expression of Smurf2, p21, and p16 was analyzed. Sox2‐Cre gene expression was normalized to 1.    The gene expression of Smurf2, p21, and p16 RNA was also determined with bone marrow and analyzed using real‐time PCR. As seen in Figure 16, Smurf2 RNA is overexpressed in Sox2‐Cre/Smurf2 (blue) mice when compared to Sox‐Cre (red) mice. The data also shows that p21 is not significantly overexpressed in Sox2‐Cre/Smurf2 mice and that p16 expression is undetectable. 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Figure 16: Smurf2 RNA is Overexpressed in Sox2‐Cre/Smurf2 mice. RNA was extracted from bone marrow in Sox2‐Cre (blue) and Sox2‐Cre/Smurf2 (red) mice. Expression of Smurf2, p21, and p16 was analyzed. Sox2‐Cre gene expression was normalized to 1. 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DISCUSSION 
Discussion   This project was successful in using shRNAmir gene knockdown screening to identify potential genes downstream of Notch3. Seven candidate genes were identified from this screening process, one of which was further investigated with five genes in the Smurf2 senescence pathway. My data suggests that knockdown of CDC42BPA allows partial escape of Smurf2 induced senescence, while knockdown of CDC42BPA does not allow significant rescue from Notch3‐induced senescence and knockdown of PIAS4 and AHCYL1 does not allow significant rescue from Smurf2‐induced senescence.   This project was also successful in determining preliminary characterization of the function of Smurf2 in senescence regulation in vivo. Smurf2 overexpression is able to impact growth and regulate p21 in young mice.  
PIAS4, AHCYL1, and CDC42BPA   PIAS4, AHCLY1, and CDC42BPA were identified as candidate genes whose down‐regulation allows the escape of Smurf2‐ or Notch3‐induced senescence in WS1 and LF1 cells.  
PIAS4  It has been suggested previously that PIAS4 is involved in senescence (Rytinki et al., 2009). PIAS, or protein inhibitors of activated STATs, is able to inhibit STAT as its name suggests (Desrivières et al., 1996). As STAT activates transcription, 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PIAS is able to inhibit transcription (Desrivières et al., 1996). PIAS4 (PIASy or gamma) is shown to act as a SUMO‐E3 ligase for Smad3 and p53 (Imoto et al., 2003).  My results indicate that knockdown of PIAS4 is not sufficient to allow fibroblasts to escape Smurf2‐induced senescence. It is possible that the level of knockdown in my experiments was not depleted enough to interfere with the function of PIAS4, or that other PIAS proteins (PIAS1‐3) compensate for the knockdown of PIAS4. In the case of compensation, a function interference of PIAS activity would be more suitable in the test of their function in Smurf2‐induced senescence. It is also possible that knockdown of PIAS4 only compromises only one of the senescence pathways, which is not sufficient for a full escape of Smurf2‐induced senescence. It will be interesting to investigate if PIAS4 collaborates with other genes in regulating Smurf2‐induced senescence.  
AHCYL1 It is known that AHCYL can regulate both senescence pathways through p53 and p16 (Leal et al., 2008). AHCYL1, or s‐adenosylhomocysteine hydrolase‐like 1, is involved in the hydrolysis of S‐adenosyl‐L‐homocysteine to L‐homocysteine and adenosine (Leal et al., 2008). Although there is little research on AHCYL1 in particular, inactivation of AHCYL in general induced cell resistance to p53 and p16‐induced replicative arrest (Leal et al., 2008). AHCYL has also been shown to inhibit p53 transcriptional activity and DNA damage‐induced transcription of p21 (Leal et al., 2008). 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My data gives evidence that knockdown of AHCYL1 is not sufficient to resuce fibroblasts from Smurf2‐induced senescence. As very good knockdown of AHCYL1 was achieved, it is likely that the level of AHCYL1 knockdown interfered with its function. A possibility is that AHCYL2 was able to compensate for the knockdown of AHCYL1, so again, a function interference of AHCYL activity might be more suitable in testing its function. An alternative reason is that AHCYL1 knockdown causes the WS1 and LF1 fibroblast cells to grow very slowly, even without the secondary infection; faster growth was unable to be achieved. So although AHCYL1 knockdown with Smurf2 WT and Smurf2 C716A challenge grew similarly to AHCYL1 knockdown with lenti‐virus control vector, all three grew similarly to non‐silencing knockdown with Smurf2 WT and Smurf2 C716A challenge.  
CDC42BPA CDC42BPA is known to regulate p53 is the senescence pathway (Sirotkin et al., 2008). CDC42BPA (CDC42 binding protein kinase alpha) knockdown is shown to inhibit the expression of p53 and PCNA, or proliferating cell nuclear antigen in ovarian cells (Sirotkin et al., 2008). PCNA promotes DNA synthesis during S phase and provides protection from apoptosis during G1 phase (Sirotkin et al., 2008). My results indicate that knockdown of CDC42BPA is not sufficient to allow fibroblasts to escape Notch3‐induced senescence; however, the knockdown was sufficient to partially rescue cells from Smurf2‐induced senescence. It is possible that the knockdown level of CDC42BPA in my experiments, while sufficient to interfere with its function while downstream of Smurf2, was not low enough to 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interfere with the function of CDC42BPA when downstream of Notch3. Because CDC42BPA is only shown to interact with one of the senescence pathways, this may not be sufficient for escape of Notch3‐induced senescence. It will be interesting to further determine the interaction of Smurf2 with CDC42BPA, as well as the interaction of CDC42BPA with other genes in the senescence pathway. This research may be able to enlighten us on if and how CDC42BPA interacts with Notch3.  
Smurf2 In Vivo   Smurf2 overexpression was able to affect growth in young mice for a short period of time. However, the mice seemed to have compensated for this abnormal development, as this stunted growth lasted for less than two months. Smurf2 overexpression in young mice seemed to adhere to a similar senescence pathway that occurs in vitro. Smurf2 was shown to regulate p21, which is consistent with in 
vitro data. However, as p16 did not seem to be regulated by Smurf2, this could have occurred due to the young age of the mice. p16 has been seen to be vastly increased during senescence (Alcorta, et al., 1996), indicating that p16 will most likely not become present in mice until an older age.   Growth rates of Smurf2 overexpressed mice should be repeated, possibly with weights being measured at more frequent intervals. Gene expression should also be determined at additional ages to determine if the expression changes as the mice age. Our lab also contains Smurf2 C716A mice, it will be interesting to see if overexpression of Smurf2 C716A gives similar consequences as Smurf2 WT overexpression. 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